Reduced Number of Hypocretin Neurons in Human Narcolepsy
暂无分享,去创建一个
Michael Aldrich | Jerome M. Siegel | J. Siegel | M. Aldrich | R. Moore | S. Gulyani | Robert Y. Moore | T. Thannickal | Thomas C. Thannickal | Robert Nienhuis | Lalini Ramanathan | Seema Gulyani | Marsha Cornford | R. Nienhuis | Lalini Ramanathan | M. Cornford
[1] A. N. van den Pol,et al. The hypocretin neuron system: an arousal system in the human brain. , 2001, Archives italiennes de biologie.
[2] Sebastiaan Overeem,et al. Hypocretin (orexin) deficiency in human narcolepsy , 2000, The Lancet.
[3] J. Siegel,et al. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. , 2000, Sleep research online : SRO.
[4] A. Reiner,et al. A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections , 1999, Journal of Neuroscience Methods.
[5] J. Siegel,et al. Narcolepsy A Key Role for Hypocretins (Orexins) , 1999, Cell.
[6] Emmanuel Mignot,et al. The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.
[7] Jon T. Willie,et al. Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.
[8] J. Siegel,et al. Locus coeruleus neurons: cessation of activity during cataplexy , 1999, Neuroscience.
[9] M. Yanagisawa,et al. Widespread distribution of orexin in rat brain and its regulation upon fasting. , 1999, Biochemical and biophysical research communications.
[10] J. Siegel,et al. Neuronal Degeneration in Canine Narcolepsy , 1999, The Journal of Neuroscience.
[11] T. Hökfelt,et al. Hypocretin/Orexin‐ and melanin‐concentrating hormone‐expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene‐related protein systems , 1998, The Journal of comparative neurology.
[12] A. N. van den Pol,et al. Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.
[13] F. Holsboer,et al. In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls , 1998, Neurology.
[14] E. Mignot,et al. Genetic and familial aspects of narcolepsy , 1998, Neurology.
[15] F E Bloom,et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] V. Howard,et al. Unbiased Stereology: Three-Dimensional Measurement in Microscopy , 1998 .
[17] J. Hillert,et al. The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. , 1995, Tissue antigens.
[18] S Koskimies,et al. The prevalence of narcolepsy: An epidemiological study of the Finnish Twin Cohort , 1994, Annals of neurology.
[19] J. Hillert,et al. The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion. , 1990, Immunogenetics.
[20] M. Kryger,et al. Principles and Practice of Sleep Medicine , 1989 .
[21] G. Mueller‐Eckhardt,et al. Cellular approach for detecting narcolepsy-specific alterations in DR2 haplotypes. , 1988, Human immunology.
[22] H. Itabashi,et al. Narcolepsy: a neuropathologic study. , 1986, Sleep.
[23] Graeme Henderson,et al. Locus Coeruleus Neurons , 1984 .